|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06108 NEW RAY MEDIC
Nominal 
0.202 -0.002 (-0.980%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -4.262% | -6.222% | -4.299% | -12.971% | -0.430% |
| ROAE (%) | -4.483% | -6.521% | -4.408% | -13.460% | -0.456% |
| Return on Capital Employed (%) | -4.659% | -6.489% | -4.561% | -14.652% | -0.439% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 12.387% | 12.233% | 25.803% | 14.758% | 8.494% |
| EBITDA Margin (%) | -11.279% | -28.873% | -30.927% | -81.126% | 1.179% |
| Pre-tax Profit Margin (%) | -15.296% | -34.126% | -44.547% | -89.434% | -1.076% |
| Net Profit Margin (%) | -15.392% | -33.012% | -44.204% | -86.829% | -0.842% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 55.940 X | 12.006 X | 68.082 X | 51.468 X | 24.830 X |
| Quick Ratio (X) | 51.914 X | 11.270 X | 62.471 X | 46.978 X | 18.402 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 2.816% | 6.785% | 2.309% | 2.629% | 4.452% |
| Total Debt / Total Assets (%) | 0.565% | 0.702% | 0.059% | 0.237% | 1.939% |
| Net Debt / Total Assets (%) | -6.174% | -12.015% | -21.087% | -28.366% | -20.741% |
| Total Debt / Shareholders' Funds (%) | 0.581% | 0.754% | 0.060% | 0.243% | 2.030% |
| Long Term Debt / Shareholders' Funds (%) | 0.397% | 0.510% | 0% | 0.056% | 0.146% |
| Net Debt / Shareholders' Funds (%) | -6.353% | -12.890% | -21.586% | -29.132% | -21.707% |
| Net Cash / (Debt) ($) | 26.952M | 60.706M | 103.666M | 153.135M | 137.314M |
| Net Cash / (Debt) per share ($) | 0.134 | 0.363 | 0.620 | 0.092 | 0.082 |
| Total Debt / Capital Employed (%) | 0.572% | 0.743% | 0.059% | 0.240% | 1.998% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 69.451 Day | 113.482 Day | 325.624 Day | 382.865 Day | 110.665 Day |
| Receivables Turnover (Day) | 200.605 Day | 224.266 Day | 324.038 Day | 182.415 Day | 34.798 Day |
| Payables Turnover (Day) | N/A | 42.650 Day | 2.489 Day | N/A | N/A |
| Remarks: | Real time quote last updated: 27/03/2026 13:32 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -20,067 |
| %Change | -35.295% |
| EPS / (LPS) | HKD -0.119 |
| NBV Per Share ($) | HKD 2.115 |